The value of combined detection of 3 indicators in diagnosis and staging of ovarian cancer
10.3969/j.issn.1673-4130.2017.02.019
- VernacularTitle:3项指标联合检测对卵巢癌诊断及分期的临床研究
- Author:
An FU
- Keywords:
ovarian cancer;
human epididymis protein 4;
carbohydrate antigen 125;
carcinoma embryonic antigen;
stag-ing diagnosis
- From:
International Journal of Laboratory Medicine
2017;38(2):198-199
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value of combined detection of serum human epididymis protein 4(HE4),carbo-hydrate antigen 125(CA125)and tumor marker(CEA)in the diagnosis and staging of ovarian cancer.Methods 90 cases of ovarian cancer(ovarian cancer group),120 cases of benign ovarian disease(ovarian benign group)and 60 cases of healthy women(healthy control group)were selected from March 2014 to 2016 March in our hospital.The levels of HE4 and CA125 and CEA were detected by immunochemiluminescence assays,the results of the three groups were compared and analyzed.Results The positive rate of 3 indicators in the ovarian cancer group was significantly higher than that of the ovarian benign group and the healthy control group (P <0.05).The positive rates of combined detection of Ⅰ-Ⅳ in ovarian cancer were 81.2%,92.1%,97.4% and 100.0%,and CEA,CA125 and HE4 joint inspection in different stages of ovarian cancer positive rate is significantly higher than that of single in-dex positive detection rate.Conclusion The clinical value of HE4,CA125,CEA combined test for the diagnosis and staging of ovar-ian cancer is significant,it is worth to be further promoted.
